Can a tumor-zapping procedure also wake up the immune system?

NCT ID NCT04892810

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This study looks at how two heat-based procedures — radiofrequency ablation and microwave ablation — affect the immune system in people with small liver cancers. Researchers will take blood samples and tissue biopsies before and after treatment to track changes in immune cells. The goal is to understand whether one method triggers a stronger immune response than the other.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
percutaneous ablation (radiofrequency or microwave)
What this could lead to
If the immune response differs between the two ablation methods, it could point toward ways to boost the body's own fight against liver cancer.
What could go wrong
This is a very small, early observational study — it is not designed to test a treatment's effectiveness, and any immune changes seen may not lead to better outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Grenoble Alpes

    Grenoble, 38043, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.